Latest News for: vertex

Edit

Vertex Resource Group Ltd. Reports Fourth Quarter and Year End 2025 Results

Canada Newswire 20 Mar 2026
VTX) - Vertex Resource Group Ltd. ("Vertex" or the "Company") reports its financial and operational results for the fourth quarter and year ended December 31, 2025 ... ABOUT VERTEX ... SOURCE Vertex Resource Group Ltd.
Edit

Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026

The Call 20 Mar 2026
As of March 20, 2026, Vertex Pharmaceuticals (NASDAQ ... Joshua Boger, Vertex was a pioneer in "rational drug design"—using structural biology to build molecules that fit specific protein targets like keys in a lock.
Edit

Vertex Now Available on Oracle Marketplace

Killeen Daily Herald 17 Mar 2026
Vertex available on Oracle Cloud Infrastructure enables rapid deployment and advanced global tax management ....
Edit

xSuite Group Announces Strategic Collaboration with Vertex

The Galveston Daily News 17 Mar 2026
AHRENSBURG, Germany--(BUSINESS WIRE)--Mar 17, 2026-- ....
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Vertex Pharmaceuticals Incorporated)

Public Technologies 17 Mar 2026
VERTEX PHARMACEUTICALS INC / MA [VRTX] 5 ... C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE 3 ... C/O VERTEX PHARMACEUTICALS INCORPORATED ... Vertex Pharmaceuticals Incorporated published this ...
Edit

I Told You – The USDX Reversed Right At the Vertex

FX Empire 11 Mar 2026
IEA Executive Director Fatih Birol called the oil market challenges “unprecedented in scale.” ....
Edit

Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc

The Call 11 Mar 2026
Check out the companies making headlines yesterday.. nLIGHT (NASDAQ. LASR) ... Vertex Pharmaceuticals (NASDAQ ... Biotech company Vertex Pharmaceuticals (NASDAQ ... Is now the time to buy Vertex Pharmaceuticals? Access our full analysis report here, it's free ... .
Edit

Vertex Announces Positive Week 36 Interim Analysis Results from the Global RAINIER Phase 3 Trial of Povetacicept (ONO Pharmaceutical Co Ltd)

Public Technologies 11 Mar 2026
Toichi Takino; "Ono") today announced that, according to a press release issued by Vertex Pharmaceuticals Incorporated (Headquarters ... local time) by Vertex, our license partner for povetacicept ... Ono's partnership with Vertex: ... About Vertex.
Edit

Vertex Pharmaceuticals Surges 8.3% as Renal Breakthrough Sparks Market Rally

The Call 11 Mar 2026
In a significant milestone for precision medicine, Vertex Pharmaceuticals (NASDAQ ... The surge reflects growing investor confidence in Vertex’s ability to diversify its revenue streams beyond its dominant cystic fibrosis franchise.
Edit

Stocks making the biggest moves premarket: Kohl's, Casey's General Stores, Vertex Pharmaceuticals and more

CNBC 10 Mar 2026
These are the stocks posting the largest moves in early trading ... .
Edit

Vertex passes key test in quest to treat kidney diseases

CNBC 10 Mar 2026
Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial ... .
×